Clinical Trial Update: Immunotherapy Study for Patients With Stage IV Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for an immunotherapy study in stage IV/metastatic melanoma; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: NewLink Genetics Corporation | Conditions: Stage IV Melanoma, Metastatic Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2020-04-29